As the disclosure of the 2026 three-quarter report for public funds came to an end, the performance performance, position structure, and investment logic of various products were all revealed. Overall, public funds focus on the development direction of new quality productivity, while deepening industrial upgrading while continuing to invest heavily in science and technology. Judging from industrial upgrading, the boom in the innovative pharmaceutical industry chain has become a new allocation direction. Yao Ming Kangde entered the top ten major stocks and became the individual stock with the largest market capitalization increase in public funds in the third quarter. From a technological perspective, the heavy position pattern continued, and there were structural changes. Zhongji Xuchuang continued to be the largest heavy stock in public funds, and Changxin Technology and Shanghai Electric Power Co., Ltd. were newly added to the top ten heavy stocks in public funds. The outstanding performance of the net worth of high-performing funds echoes the direction of increasing public equity positions.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.